List To Watch: U.S. Global Investors,, FEI Company (NASDAQ:FEIC), BB&T Corporation (NYSE:BBT), Voyager Therapeutics (NASDAQ:VYGR), Ariad Pharmaceuticals (NASDAQ:ARIA)

U.S. Global Investors, Inc. (NASDAQ:GROW) shares moved up 2.56% in last trading session and ended the day at $1.60. GROW Gross Margin is 80.30% and its has a return on assets of -20.70%. U.S. Global Investors, Inc. (NASDAQ:GROW) quarterly performance is 24.83%.

U.S. Global Investors, Inc. (NASDAQ: GROW), will continue its payment of monthly dividends in the second calendar quarter of 2016. The company’s board of directors approved payment of the $0.0025 per share per month dividend beginning in April 2016 and continuing through June 2016. The record dates are April 11, May 16 and June 13, and the payment dates will be April 25, May 31 and June 27.

FEI Company (NASDAQ:FEIC) ended the last trading day at $85.95. Company weekly volatility is calculated as 2.16% and price to cash ratio as 11.67. FEI Company (NASDAQ:FEIC) showed a weekly performance of -1.14%.

FEI Company (NASDAQ:FEIC) announced that its board of directors has approved payment of a quarterly dividend of $0.30 per share of common stock. The dividend will be paid on April 19, 2016 to shareholders of record as of the close of business on April 6, 2016.

On 28 March, BB&T Corporation (NYSE:BBT) shares moved down -0.39% and was closed at $33.56. BBT EPS growth in last 5 year was 17.10%. BB&T Corporation (NYSE:BBT) year to date (YTD) performance is -10.48%.

On March 15, 2016, BB&T Corporation (NYSE:BBT) and National Penn Bancshares, Inc. (“National Penn”) issued a press release reminding National Penn security holders that (1) BB&T’s previously announced merger with National Penn (the “Merger”), pursuant to the Agreement and Plan of Merger, dated as of August 17, 2015, by and between National Penn and BB&T (the “Merger Agreement”), is expected to close on or about April 1, 2016, and (2) the election deadline for holders of National Penn common stock and certain National Penn equity awards to elect the form of consideration they wish to receive in the Merger, subject to the allocation and proration procedures set forth in the Merger Agreement, will be 5:00 p.m., Eastern Daylight Time, on March 30, 2016, unless extended.

Voyager Therapeutics, Inc. (NASDAQ:VYGR) shares remains unchanged in last trading session and ended the day at $8.74. VYGR has a return on assets of -41.00%. Voyager Therapeutics, Inc. (NASDAQ:VYGR) quarterly performance is -57.78%.

On 17 March, Voyager Therapeutics Inc. (NASDAQ:VYGR) reported a loss of $7.3 million in its fourth quarter. The Cambridge, Massachusetts-based company said it had a loss of 67 cents per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share. The gene therapy company posted revenue of $4.9 million in the period. For the year, the company reported profit of $29.7 million, or $9.14 per share. Revenue was reported as $17.3 million.

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) caters to the Healthcare space. Its weekly performance is -3.99%. On the last day of trading company shares ended up at $6.02.

On March 17, 2016, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) entered into an Amendment (the “Amendment”) to the Agreement, dated as of April 28, 2015 (the “Settlement Agreement”), between the Company and Sarissa Capital Management LP, Sarissa Capital Domestic Fund LP, Sarissa Capital Offshore Master Fund LP, Sarissa Capital Fund GP LP and Sarissa Capital Offshore Fund GP LLC (collectively, the “Sarissa Group”).

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *